ask="18.49"
ask_size="100"
average_daily_volume="281221"
bid="17.26"
bid_size="100"
book_value="3.21"
change="-0.09"
change_from_200_day_moving_average="5.82"
change_from_50_day_moving_average="1.54"
change_from_52_week_high="-5.04"
change_From_52_week_low="13.39"
change_in_percent="-0.50%"
close="18.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6551000"
high="18.50"
high_52_weeks="23.07"
last_trade_date="1/23/2017"
last_trade_price="18.03"
last_trade_size="2237"
last_trade_time="4:00pm"
low="17.90"
low_52_weeks="4.64"
market_capitalization="179.45M"
moving_average_200_day="12.21"
moving_average_50_day="16.49"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="18.12"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+47.69%"
percent_change_from_50_day_moving_average="+9.36%"
percent_change_from_52_week_high="-21.84%"
percent_change_from_52_week_low="+288.58%"
previous_close="18.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.65"
price_per_sales="3190.65"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="8.35"
stock_exchange="NGM"
symbol="ZYNE"
volume="632808"
weeks_range_52="4.64 - 23.07"
